Lenvanamo-10 is a prescription antineoplastic (anticancer) medicine containing Lenvatinib 10 mg per capsule, supplied as a pack of 30 capsules by Shivnaam Tradelink LLP (India). It is an oral tyrosine kinase inhibitor and is used only under the supervision of a cancer specialist.
Lenvatinib is a multi-kinase inhibitor that blocks several receptor tyrosine kinases involved in tumour growth and blood-vessel formation. On prescription it is used in adults for certain cancers, including differentiated (papillary or follicular) thyroid cancer that no longer responds to radioactive iodine, hepatocellular carcinoma (liver cancer), renal cell carcinoma, and in combination regimens for endometrial carcinoma. The exact indication and dose are decided by the treating oncologist.
Lenvatinib is taken by mouth, usually once a day at about the same time each day, with or without food. The dose depends on the indication, body weight and how the medicine is tolerated, and it may be adjusted or paused by the oncologist. Use it exactly as prescribed.
Common effects include high blood pressure, fatigue, diarrhoea, nausea, vomiting, reduced appetite and weight loss, hand-foot skin reaction, mouth sores, hoarseness, an underactive thyroid and protein in the urine. Serious effects can include bleeding, liver problems, kidney problems, heart-rhythm changes (QT prolongation) and blood clots. Report any new or worsening symptoms to your doctor promptly.
Store at room temperature (below 30 °C) in the original container, protected from light and moisture, out of reach of children. Do not use after the expiry date printed on the pack.
The photo is used for identification of the product. This information does not replace medical advice and is not a substitute for a consultation with a qualified healthcare professional. This is a prescription medicine. Availability and delivery terms may differ by country.
📦 Ask about availability and delivery to your country on WhatsApp




